Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion-Reference-Cited by-同舟云学术

Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion

Published:2010-06-15 Issue:10 Volume:30 Page:1427-1438
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Chen Pei-Jer,Furuse Junji,Han Kwang-Hyub,Hsu Chiun,Lim Ho-Yeong,Moon HanLim,Qin Shukui,Ye Sheng-Long,Yeoh Ee-Min,Yeo Winnie

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2010.02292.x/fullpdf

Reference64 articles.

1. Patterns of cancer incidence, mortality, and prevalence across five continents;Kamangar;defining priorities to reduce cancer disparities in different geographic regions of the world,2006

2. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

3. Asia pacific working party on prevention of hepatocellular carcinoma. Hepatocellular carcinoma in the Asia pacific region;Yuen;J Gastroenterol Hepatol,2009

4. Panel of experts in HCC-design clinical trials. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J Natl Cancer Inst,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial;The Lancet Gastroenterology & Hepatology;2021-07

2. DLX6-AS1: a putative lncRNA candidate in multiple human cancers;Expert Reviews in Molecular Medicine;2021

3. Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest, apoptosis, and autophagy in liver cancer cells;Journal of Cancer;2020

4. Role of miRNA sponges in hepatocellular carcinoma;Clinica Chimica Acta;2020-01

5. The Dnazyme Anti-insulin-like Growth Factor-IIP3 Inhibited Tumour Growth in a Mouse Model of Human Hepatocarcinoma;Current Science;2019-06-25